Skip to main content

Table 1 Baseline patient characteristics and outcomes for the total study sample and for the four groups based on goal classes. Mean (SD) or N (%)

From: Associations between treatment goals, patient characteristics, and outcome measures for patients with musculoskeletal disorders in physiotherapy practice

 

Total N = 2591 (100%)

Symptom only N = 440 (17.0%)

Function/structure included N = 838 (32.3%)

Activity/participation included N = 1122 (43.3%)

Non-classifiable N = 191 (7.4%)

P

Characteristics

 Age years, mean (SD)

48.4 (18.1)

42.4 (16.9) bcd*

52.0 (16.8) ac*

47.5 (18.8) a*

50.9 (17.9) a*

<.001

 Gender female, N (%)

1763 (69.5)

330 (76.7)

563 (68.1)

723 (66.5)

147 (77.4)

<.001

 BMI, mean (SD)

26.6 (10.4)

25.5 (4.9)

27.3 (13.1)

26.6 (10.2)

25.8 (4.5)

.092

 Severity (0–10) N (%)

5.3 (1.7)

5.0 (1.7) c*

5.3 (1.6)

5.5 (1.7) a*

5.4 (1.6)

<.001

 Body region/diagnosis N (%)

     

<.001

  Spinal

750 (28.9)

211 (47.7)

220 (25.8)

259 (23.5)

60 (30.0)

 

  Upper extremities

504 (19.4)

68 (15.4)

228 (26.7)

187 (17.0)

21 (10.5)

 

  Lower extremities

1118 (43.0)

107 (24.2)

344 (40.3)

595 (53.2)

72 (36.0)

 

  Unspecific/ multisite conditions

225 (8.7)

56 (12.7)

61 (7.2)

61 (5.5)

47 (23.5)

 

 Emotional distress (HSCL10, score 1–4), mean (SD)

1.62 (.51)

1.66 (.51) d*

1.60 (.49) d*

1.60 (.50) d*

1.86 (.61) abc*

.001

 Treatment beliefs, N (%)

1776

    

.021

  Totally agree

994 (56.0)

128 (46.2)

332 (59.0)

466 (57.5)

68 (54.4)

 

  Agree

658 (37.0)

120 (43.3)

194 (34.5)

299 (36.9)

45 (36.0)

 

  Neither agree nor disagree

122 (6.9)

29 (10.5)

36 (6.4)

45 (5.5)

12 (9.6)

 

  Disagree

2 (0.1)

0 (0)

1 (0.2)

1 (0.1)

0 (0)

 

 Duration, N (%)

1817

    

.575

   < 3 m

386 (21.2)

77 (24.1)

119 (19.6)

162 (21.8)

28 (19.2)

 

  3-12 m

518 (28.5)

85 (26.6)

170 (28.0)

222 (29.9)

41 (28.1)

 

   > 12 m

913 (50.2)

158 (49.4)

319 (52.5)

359 (48.3)

77 (52.7)

 

 Education, N (%)

2072

    

.350

  High school or less

826 (39.9)

124 (36.5)

276 (40.5)

374 (41.5)

52 (34.9)

 

  Up to 4y higher seducation

663 (32.0)

118 (34.7)

211 (31.8)

276 (30.6)

58 (38.9)

 

  4y higher education sor more

583 (28.1)

98 (28.8)

195 (28.6)

251 (27.9)

39 (26.2)

 

Outcome measures

 Global perceived effect – Improved

900 (65.0)

122 (55.5)

290 (64.2)

429 (71.1)

59 (54.1)

<.001

 Main goal achieved

439 (42.6)

64 (42.7)

123 (37.4)

201 (45.8)

51 (50.0)

.081

 PSFS change (− 10 to 10)

2.94 (2.98)

2.61 (2.96)

3.05 (2.94)

3.13 (3.04) d*

2.23 (2.7) c*

.022

 Pain intensity change (−10 to 10)

−1.12 (2.40)

− 1.19 (2.36) d*

−0.98 (2.35)

−1.34 (2.41) d*

−0.31 (2.43) ac*

<.001

  1. M Mean, SD Standard deviation, HSCL10 Hopkins Symptom Check List 10 item version, higher is worse. Severity = average of pain intensity last week (0–10) and inverted rating of PSFS (0–10), higher is worse. y = years, m = months. P = X2/ANOVA. a: compared to symptom, b: compared to function/structure, c: compared to activity/participation, d: compared to non-classifiable. *: post hoc bonferroni ≤.05